Related references
Note: Only part of the references are listed.Sacubitril-Valsartan Increases Ultrafiltration in Patients Undergoing Peritoneal Dialysis: A Short-Term Retrospective Self-Controlled Study
Fen Zhang et al.
FRONTIERS IN MEDICINE (2022)
Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Retrospective Multi-Institutional Study
Fu-Chih Hsiao et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Cardiovascular Disease in Chronic Kidney Disease Pathophysiological Insights and Therapeutic Options
Joachim Jankowski et al.
CIRCULATION (2021)
Heart Failure Primary Prevention: What Does SPRINT Add? Recent Advances in Hypertension
Kirsten Raby et al.
HYPERTENSION (2021)
Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis
Sha Fu et al.
FRONTIERS IN MEDICINE (2021)
Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal disease
Seonhwa Lee et al.
ESC HEART FAILURE (2020)
Neprilysin expression and functions in development, ageing and disease
N. N. Nalivaeva et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2020)
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation
Hung-Yu Chang et al.
JOURNAL OF CARDIOLOGY (2019)
Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology
Stefano Bianchi et al.
JOURNAL OF NEPHROLOGY (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of Volume Overload and Current Techniques for the Assessment of Fluid Status in Patients with Renal Disease
Can Ekinci et al.
BLOOD PURIFICATION (2018)
Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study
Deanna G. Cheung et al.
JOURNAL OF CLINICAL HYPERTENSION (2018)
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Kevin Damman et al.
JACC-HEART FAILURE (2018)
Heart Failure in End-Stage Kidney Disease: Pathophysiology, Diagnosis, and Therapeutic Strategies
Janani Rangaswami et al.
SEMINARS IN NEPHROLOGY (2018)
The Transition From Hypertension to Heart Failure
Franz H. Messerli et al.
JACC-Heart Failure (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach
Oriol Iborra-Egea et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
A Test in Context: Neprilysin Function, Inhibition, and Biomarker
Antoni Bayes-Genis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli et al.
LANCET (2015)
Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
Kazuomi Kario et al.
HYPERTENSION (2014)
Effects of Spironolactone on Dialysis Patients With Refractory Hypertension: A Randomized Controlled Study
Xiaoying Ni et al.
JOURNAL OF CLINICAL HYPERTENSION (2014)
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Alberto Ortiz et al.
LANCET (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort et al.
LANCET (2013)
Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis
Andreas Fusshoeller
PEDIATRIC NEPHROLOGY (2008)
Oxidative stress during peritoneal dialysis: Implications in functional and structural changes in the membrane
H. Noh et al.
KIDNEY INTERNATIONAL (2006)
Molecular physiology of natriuretic peptide signalling
M Kuhn
BASIC RESEARCH IN CARDIOLOGY (2004)
Share Paper
